Showing results (41-50 of 253) with videos related to
Sort By:
Pageof 26
Frontiers in Pharmacology|December 26, 2023
Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugsAlessia Greco, Francesca Coperchini, Laura Croce, et al.Journal of Neuroimmunology|March 5, 2011
Interferon-β but not Glatiramer acetate stimulates CXCL10 secretion in primary cultures of thyrocytes: a clue for understanding the different risks of thyroid dysfunctions in patients with multiple sclerosis treated with either of the two drugsMario Rotondi, Francesca Stufano, Maria Stefania Lagonigro, et al.Neuroimmunomodulation|September 7, 2013
Severe disability in patients with relapsing-remitting multiple sclerosis is associated with profound changes in the regulation of leptin secretionMario Rotondi, Anna Paola Batocchi, Francesca Coperchini, et al.Frontiers in Endocrinology|October 17, 2017
Autoimmune Thyroid Diseases in Patients Treated with Alemtuzumab for Multiple Sclerosis: An Example of Selective Anti-TSH-Receptor Immune ResponseMario Rotondi, Martina Molteni, Paola Leporati, et al.Frontiers in Endocrinology|October 18, 2021
COVID-19-Associated Subacute Thyroiditis: Evidence-Based Data From a Systematic ReviewPierpaolo Trimboli, Carlo Cappelli, Laura Croce, et al.The Journal of Clinical Endocrinology and Metabolism|January 31, 2020
The Detection of Serum IgMs to Thyroglobulin in Subacute Thyroiditis Suggests a Protective Role of IgMs in Thyroid AutoimmunityDebora Ricci, Alessandro Brancatella, Michele Marinò, et al.Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 20, 2016
GENDER INFLUENCES THE CLINICAL PRESENTATION AND LONG-TERM OUTCOME OF GRAVES DISEASEFlavia Magri, Francesca Zerbini, Margherita Gaiti, et al.Endocrine-Related Cancer|April 8, 2025
Sexual dimorphism in thyroid cancer: evidence from preclinical studiesFrancesca Coperchini, Alessia Greco, Paolo Caccavale, et al.Environment International|May 10, 2024
Do PFCAs drive the establishment of thyroid cancer microenvironment? Effects of C6O4, PFOA and PFHxA exposure in two models of human thyroid cells in primary cultureFrancesca Coperchini, Alessia Greco, Laura Croce, et al.Frontiers in Endocrinology|July 31, 2023
Thyroid hormones modifications among COVID-19 patients undergoing pulmonary rehabilitationLaura Croce, Elisabetta Zampogna, Francesca Coperchini, et al.Pageof 26